Related Experiment Video

Updated: Aug 22, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.7K

Peptide-Drug Conjugates: A New Hope for Cancer Management

Vivek P Chavda1, Hetvi K Solanki1, Majid Davidson2

  • 1Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, Gujarat, India.

Molecules (Basel, Switzerland)
|November 11, 2022
PubMed

Insights

Peptide conjugates offer a promising next generation of cancer therapeutics, improving drug delivery and reducing toxicity. These advanced treatments aim for precise targeting in efficient cancer management.

Area of Science:

  • Oncology
  • Biotechnology
  • Drug Development

Background:

  • Cancer is a leading global cause of mortality, necessitating novel and effective therapeutic strategies.
  • Short peptides present unique advantages for cancer management, including versatility and improved biotechnological applications.
  • Existing peptide limitations are being overcome through advanced drug delivery systems.

Purpose of the Study:

  • To provide an overview of peptide conjugates as next-generation cancer therapeutics.
  • To highlight peptide conjugates as superior alternatives to antibody-drug conjugates.
  • To discuss the development, challenges, and potential of peptide-drug conjugates in cancer treatment.

Main Methods:

  • Review of current literature on peptide conjugates and their therapeutic applications in oncology.
  • Analysis of the components and mechanisms of action for peptide-drug conjugates.
  • Examination of clinical development stages and regulatory considerations for peptide-based therapies.

Main Results:

  • Peptide conjugates demonstrate precise targeting, enhanced cellular permeability, and improved drug selectivity.
  • These conjugates offer reduced toxicity compared to conventional treatments.
  • Various peptide-drug conjugates are progressing through clinical development stages.

Conclusions:

  • Peptide conjugates represent a significant advancement in cancer therapy, offering enhanced efficacy and safety.
  • Further development and regulatory navigation are crucial for the clinical success of peptide-drug conjugates.
  • Peptide-based therapeutics hold substantial promise for the future of precise cancer treatment.
Keywords:
cancerdrug deliverypeptide-drug conjugatesshort peptides

More Related Videos

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.5K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
488
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
638
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.7K